This inventor holds 2 USPTO granted patents. Top assignee: Cogent Limited. Active years: 2000-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2003
Title: Barclay George Barrell: Innovator in HCMV Research
Introduction: Barclay George Barrell is a distinguished inventor based in Cambridge, GB. He has made significant contributions to the field of virology, particularly in the study of human cytomegalovirus (HCMV). With a total of 2 patents to his name, Barrell's work has the potential to impact vaccine development and antibody detection.
Latest Patents: His latest patents focus on processes for the production of HCMV glycoproteins, antibodies thereto, and HCMV vaccines. The patents detail the identification of glycoproteins B and H, which are encoded by specific DNA fragments within the HCMV genome. These glycoproteins have been incorporated into recombinant vaccinia vectors and expressed in host animals to raise HCMV-neutralizing antibodies, indicating their potential as vaccines. Additionally, these glycoproteins can be utilized in various applications, including the production, purification, or detection of HCMV antibodies.
Career Highlights: Barclay George Barrell is currently associated with Cogent Limited, where he continues to advance research in HCMV. His innovative approaches have garnered attention in the scientific community, contributing to the understanding of viral mechanisms and potential therapeutic interventions.
Collaborations: Throughout his career, Barrell has collaborated with notable colleagues, including Geoffrey Lilley Smith and Martin Patrick Cran
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile